Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Adverse Events Following Immunization Among Children With Epilepsy: A Self-Controlled Case Series
Karina A Top1,2, Christiaan H Righolt3, Steven Hawken4,5,6
1From the Departments of Pediatrics.
Insights
In children with epilepsy, a modest increase in seizure-related emergency visits occurred after inactivated and live vaccines. This risk is small compared to the dangers of vaccine-preventable diseases.
Area of Science:
- Pediatrics
- Neurology
- Immunology
Background:
- Fever and illness can trigger seizures in children with epilepsy.
- Concerns exist that vaccine-induced inflammation and fever might also trigger seizures.
- This study investigated the risk of seizures following immunization in children with epilepsy.
Purpose of the Study:
- To estimate the risk of emergency department (ED) visits or hospitalizations for epilepsy/seizure after immunization in children younger than 7 years with epilepsy.
- To assess the risk of all-cause ED visits or hospitalizations post-immunization in this population.
Main Methods:
- A self-controlled case series design was used, analyzing administrative healthcare data from Ontario and Manitoba, Canada (2005-2015).
- Children diagnosed with epilepsy before age 7 and immunized were included.
- Age- and season-adjusted relative incidence (aRI) of ED visits/hospitalizations was calculated for specific periods post-inactivated and live immunizations compared to a control period.
Main Results:
- The risk of epilepsy/seizure-related ED visits/hospitalizations modestly increased 0-2 days after inactivated vaccines (aRI = 1.5) and 7-10 days after live vaccines (aRI = 1.9).
- All-cause ED visits/hospitalizations showed a combined aRI of 0.9 after inactivated vaccines and 1.3 after live vaccines during the respective risk periods.
- These findings indicate a slight increase in seizure risk following vaccination in children with epilepsy.
Conclusions:
- The risk of epilepsy/seizure-related ED visits/hospitalizations is modestly increased in children with epilepsy following inactivated and live vaccines.
- This increased risk occurs during periods of peak fever and inflammation post-vaccination.
- These risks should be weighed against the significant benefits of protection from vaccine-preventable diseases.
Background:
In children with epilepsy, fever and illness are known triggers for seizure; therefore, clinicians and parents could be concerned that immunization-induced inflammation and fever could also trigger seizures. We sought to estimate the risk of emergency department (ED) visit or hospitalization for epilepsy/seizure and all causes after immunization in children younger than 7 years of age with epilepsy.
Methods:
We conducted a self-controlled case series of children diagnosed with epilepsy before their 7th birthday and immunized from 2005 to 2015 in Ontario (population 14.2 million) and Manitoba (population 1.3 million), Canada, using administrative healthcare data. We estimated the age- and season-adjusted relative incidence (aRI) of epilepsy/seizure-related and all-cause ED visits/hospitalizations during various risk periods 0-28 days after inactivated and live immunizations versus a control period 35-83 days postimmunization. Estimates from each province were analyzed separately and then combined in a random-effects meta-analysis.
Results:
The combined risk of epilepsy/seizure-related hospitalization/ED visit was increased 0-2 days after inactivated vaccines (aRI = 1.5, 95% confidence interval: 1.1-1.9) and 7-10 days after live vaccines (aRI = 1.9, 1.4-2.7). For all-cause ED visit/hospitalization, the combined aRI estimate was 0.9 (0.8-1.2) 0-2 days after inactivated vaccines and 1.3 (1.1-1.5) 7-10 days after live vaccines.
Conclusions:
The risk of epilepsy/seizure-related ED visit/hospitalization was modestly increased among children with epilepsy during peak periods of fever and inflammation following inactivated and live vaccines. These risks must be balanced against the risk of complications from vaccine-preventable diseases.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Vaccinations

